BRIEF-Synlogic and Mirna therapeutics agree to merger

* Mirna Therapeutics Inc says first clinical trial for lead Synlogic product candidate anticipated to start mid-2017
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.